Search clinical trials for: Wild Type p53 Gene Induction
Total 305679 results
-
CelltrionRecruitingRelapsing-remitting Multiple SclerosisPoland
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Department of Health and Human ServicesTerminated
-
Shenzhen SiBiono GeneTech Co.,LtdUnknownAdvanced Oral and Maxillofacial Malignant TumorsChina
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Stage I Bladder Cancer | Stage II Bladder CancerUnited States
-
Novartis PharmaceuticalsCompletedSolid Tumor With p53 Wild Type StatusFrance, Germany, Singapore, Switzerland, United States
-
Joaquina BarandaActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Cancer | Solid Tumor | Malignant Disease | Relapsed Hematologic MalignancyUnited States
-
Shenzhen SiBiono GeneTech Co.,LtdUnknownHCC | DiabetesChina
-
Moy-Fincher-Chipps Facial Plastics and DermatologyUnknown
-
Shenzhen SiBiono GeneTech Co.,LtdUnknown
-
Shenzhen SiBiono GeneTech Co.,LtdUnknownAdvanced Hepatocellular Carcinoma (HCC)China
-
Altor BioScienceNational Cancer Institute (NCI)CompletedTransitional Cell Carcinoma of Bladder | Urethra Cancer | Ureter Cancer | Malignant Tumor of Renal PelvisUnited States
-
Altor BioScienceNational Cancer Institute (NCI)CompletedMetastatic MelanomaUnited States
-
University of Texas Southwestern Medical CenterNational Cancer Institute (NCI)CompletedOvarian Cancer | Peritoneal Cavity CancerUnited States
-
Altor BioScienceNational Cancer Institute (NCI)TerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
French Innovative Leukemia OrganisationJanssen, LPActive, not recruitingRelapsed or Refractory Chronic Lymphocytic LeukemiaFrance
-
National Cancer Institute (NCI)CompletedLip and Oral Cavity Cancer | Oropharyngeal Cancer | Tongue Cancer | Stage 0 Lip and Oral Cavity Cancer | Stage 0 Oropharyngeal CancerUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
Shanghai Changzheng HospitalUnknownRefractory Cancer | Arsenic Trioxide | p53 Mutations | Intractable CancerChina
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
First Affiliated Hospital of Jinan UniversityRuijin HospitalRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | P53 Mutation | Myeloid Malignancy | Temperature-Sensitive p53 Mutation | Sodium StibogluconateChina
-
The Netherlands Cancer InstituteMerck Sharp & Dohme LLCCompletedEpithelial Ovarian CancerNetherlands
-
Ruijin HospitalRecruitingP53 Mutation | Myeloid Malignancy | MDS | AmlChina
-
National Cancer Institute (NCI)Completed
-
Altor BioScienceJames and Esther King Biomedical Research ProgramUnknownNon-muscle Invasive Bladder CancerUnited States
-
Aventis PharmaceuticalsUnknownHead and Neck CancerUnited States
-
Federal University of São PauloCompletedPhotoaging | Epidermal p53 ExpressionBrazil
-
Huazhong University of Science and TechnologyRecruitingDiffuse Large B Cell LymphomaChina
-
PMV Pharmaceuticals, IncMerck Sharp & Dohme LLCRecruitingBreast Cancer | Head and Neck Cancer | Colorectal Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Metastatic Cancer | Advanced Solid Tumor | Endometrial Cancer | Metastatic Solid Tumor | Other Cancer | Advanced Malignant Neoplasm | Locally AdvancedUnited States, Spain, Korea, Republic of, Australia, France, Germany, Italy, Singapore, United Kingdom
-
Eleos, Inc.H. Lee Moffitt Cancer Center and Research InstituteTerminatedMyelodysplastic SyndromesUnited States
-
National Cancer Institute (NCI)CompletedNeoplasm Metastasis | Breast NeoplasmUnited States
-
Shenzhen SiBiono GeneTech Co.,LtdUnknown
-
National Cancer Institute (NCI)CompletedBrain and Central Nervous System Tumors
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Platinum-Resistant Ovarian Carcinoma | Recurrent Platinum-Resistant Fallopian Tube Carcinoma | Recurrent Platinum-Resistant Primary Peritoneal CarcinomaUnited States
-
University Medical Center GroningenISA Pharmaceuticals B.V.; Dutch Cancer SocietyCompletedOvarian CancerNetherlands
-
Shenzhen SiBiono GeneTech Co.,LtdUnknownAdvanced Head and Neck CancerChina
-
Affiliated Hospital of Jiangnan UniversityCompleted
-
Sohag UniversityNot yet recruitingInvasive Breast Cancer
-
Merck Sharp & Dohme LLCCompletedOvarian Cancer | Fallopian Tube Cancer | Metastatic Cancer | Primary Peritoneal Cavity Cancer
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
Novartis PharmaceuticalsTerminatedAcute Myeloid Leukemia | Allogeneic Stem Cell TransplantationItaly, Germany, Spain
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid LeukemiaItaly, Hong Kong, Israel, Hungary, Turkey, Malaysia, United States
-
Sunnybrook Health Sciences CentreNovartisCompleted
-
Altor BioScienceCompletedProgressive Metastatic MalignanciesUnited States
-
Leiden University Medical CenterUniversity Medical Center GroningenCompletedRecurrent Ovarian CancerNetherlands
-
PMV Pharmaceuticals, IncActive, not recruitingHealthy VolunteersUnited States
-
Dana-Farber Cancer InstituteCookies for Kids' Cancer; Aileron Therapeutics, Inc.; TeamConnor Childhood Cancer...CompletedLymphoma | Leukemia | Solid Tumor | Brain TumorUnited States
-
European Society for Blood and Marrow TransplantationEuropean Research Initiative on CLLCompletedCLLGermany, United Kingdom, Netherlands, Finland, Sweden, Denmark, Israel
-
Leiden University Medical CenterCanadian Institutes of Health Research (CIHR); AstraZeneca; National Cancer Institute... and other collaboratorsRecruitingEndometrial CancerNetherlands, Canada, France, United Kingdom
-
Mario Negri Institute for Pharmacological ResearchAssociazione Italiana per la Ricerca sul CancroCompletedTriple Negative Breast CancerItaly